期刊
JOURNAL OF NEUROLOGY
卷 265, 期 8, 页码 1880-1882出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00415-018-8931-7
关键词
Progressive multifocal leukoencephalopathy; PML; Dimethylfumarate; Multiple sclerosis
资金
- Biogen idec
- Bayer Vital
- Teva Pharmaceutical Industries Ltd.
- Bayer Schering Pharma
- Genzyme
- Merck Serono
- Novartis
We report a 76-year-old MS patient, treated with DMF for 3 years. Lymphocytes never showed values below 1240/mu l. CSF analysis revealed 1,988,880 copies/ml of JCV-DNA, JCV-DNA was detectable in serum and anti-JCV-antibody in CSF and serum were highly positive. StratifyA (R)-JCV-test was positive. CD8-positive T-lymphocytes were reduced. Therapy with mefloquine, mirtazapine and cidofovir resulted in complete elimination of the virus in serum and 90% reduction of viral load in CSF. This case shows that despite careful monitoring for lymphopenia JCV spreading to the CSF may occur during treatment with DMF.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据